title: Vibrio cholerae flagellins induce Toll-like receptor 5-mediated interleukin-8 production through mitogen-activated protein kinase and NF-kappaB activation.
abstract: Vaccine reactogenicity has complicated the development of safe and effective live, oral cholera vaccines. Delta ctx Vibrio cholerae mutants have been shown to induce inflammatory diarrhea in volunteers and interleukin-8 (IL-8) production in cultured intestinal epithelial cells. Bacterial flagellins are known to induce IL-8 production through Toll-like receptor 5 (TLR5). Since the V. cholerae genome encodes five distinct flagellin proteins, FlaA to FlaE, with homology to conserved TLR5 recognition regions of Salmonella FliC, we hypothesized that V. cholerae flagellins may contribute to IL-8 induction through TLR5 and mitogen-activated protein kinase (MAPK) signaling. Each purified recombinant V. cholerae flagellin induced IL-8 production in T84 intestinal epithelial cells and also induced nuclear factor kappa B (NF-kappaB) activation in HEK293T/TLR5 transfectants, which was blocked by cotransfection with a TLR5 dominant-negative construct, demonstrating TLR5 specificity. Supernatants derived from Delta flaAC and Delta flaEDB mutants induced IL-8 production in HT-29 intestinal epithelial cells and in HEK293T cells overexpressing TLR5, whereas Delta flaABCDE supernatants induced significantly less IL-8 production, demonstrating the contribution of multiple flagellins in IL-8 induction. NF-kappaB activation by Delta flaABCDE supernatants was partially restored by flaA or flaAC complementation. Western analysis confirmed the presence of V. cholerae flagellins in culture supernatants. Purified recombinant V. cholerae FlaA activated the MAPKs p38, c-jun N-terminal kinase (JNK), and extracellular regulated kinase (ERK) in T84 cells. FlaA-induced IL-8 production in T84 cells was inhibited by the p38 inhibitor in combination with either the JNK or ERK inhibitors. Collectively, these data suggest that V. cholerae flagellins are present in culture supernatants and can induce TLR5- and MAPK-dependent IL-8 secretion in host cells.
authors.affiliation: Department of Microbiology and Immunology, University of Maryland Baltimore School of Medicine, Baltimore, Maryland 21201, USA.
authors.forename: Lisa M
authors.initials: LM
authors.lastname: Harrison
authors.forename: Prasad
authors.initials: P
authors.lastname: Rallabhandi
authors.forename: Jane
authors.initials: J
authors.lastname: Michalski
authors.forename: Xin
authors.initials: X
authors.lastname: Zhou
authors.forename: Susan R
authors.initials: SR
authors.lastname: Steyert
authors.forename: Stefanie N
authors.initials: SN
authors.lastname: Vogel
authors.forename: James B
authors.initials: JB
authors.lastname: Kaper
mesh_terms: D000595:Amino Acid Sequence; D015153:Blotting, Western; D002460:Cell Line; D004789:Enzyme Activation / Q000276:immunology; D005408:Flagellin / Q000235:genetics / Q000276:immunology*; D006801:Humans; D016209:Interleukin-8 / Q000096:biosynthesis*; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism*; D008969:Molecular Sequence Data; D016328:NF-kappa B / Q000378:metabolism*; D017386:Sequence Homology, Amino Acid; D051198:Toll-Like Receptor 5; D014734:Vibrio cholerae / Q000276:immunology*
chemical_list: D016209:Interleukin-8; D016328:NF-kappa B; C495346:TLR5 protein, human; D051198:Toll-Like Receptor 5; D005408:Flagellin; D020928:Mitogen-Activated Protein Kinases